Ultragenyx to Present at the JMP Securities Healthcare Conference

June 18, 2014 1:03 PM

4 0

Ultragenyx Pharmaceutical Inc. /quotes/zigman/24582850/delayed/quotes/nls/rare RARE +5.38% , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer, will be presenting at the JMP Securities Healthcare Conference on June 25, 2014 at 2:30pm ET at the Westin New York Grand Central.

The live and archived webcast of the company presentation will be accessible from the company's website at http://ir.ultragenyx.com/events.cfm . The replay of the webcast will be available approximately one hour after the conclusion of the live presentation and will be available for 180 days.

Read more

To category page